NeueHealth Statistics
Total Valuation
NeueHealth has a market cap or net worth of $58.64 million. The enterprise value is $203.86 million.
Important Dates
The next confirmed earnings date is Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NeueHealth has 8.62 million shares outstanding. The number of shares has increased by 3.42% in one year.
| Current Share Class | 8.62M |
| Shares Outstanding | 8.62M |
| Shares Change (YoY) | +3.42% |
| Shares Change (QoQ) | -0.68% |
| Owned by Insiders (%) | 8.02% |
| Owned by Institutions (%) | 12.55% |
| Float | 3.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.06 |
| Forward PS | 0.05 |
| PB Ratio | -0.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.61
| Current Ratio | 0.61 |
| Quick Ratio | 0.32 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.91 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -6.49% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 55.38% |
| Revenue Per Employee | $949,956 |
| Profits Per Employee | -$188,976 |
| Employee Count | 986 |
| Asset Turnover | 1.06 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NeueHealth has paid $2.60 million in taxes.
| Income Tax | 2.60M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.26% in the last 52 weeks. The beta is 0.55, so NeueHealth's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +5.26% |
| 50-Day Moving Average | 6.63 |
| 200-Day Moving Average | 5.92 |
| Relative Strength Index (RSI) | 56.36 |
| Average Volume (20 Days) | 12,894 |
Short Selling Information
The latest short interest is 9,947, so 0.12% of the outstanding shares have been sold short.
| Short Interest | 9,947 |
| Short Previous Month | 12,250 |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.27% |
| Short Ratio (days to cover) | 0.37 |
Income Statement
In the last 12 months, NeueHealth had revenue of $936.66 million and -$186.33 million in losses. Loss per share was -$22.65.
| Revenue | 936.66M |
| Gross Profit | 194.52M |
| Operating Income | -91.84M |
| Pretax Income | -994.38M |
| Net Income | -186.33M |
| EBITDA | -76.20M |
| EBIT | -91.84M |
| Loss Per Share | -$22.65 |
Full Income StatementBalance Sheet
The company has $93.17 million in cash and $228.52 million in debt, giving a net cash position of -$145.23 million or -$16.84 per share.
| Cash & Cash Equivalents | 93.17M |
| Total Debt | 228.52M |
| Net Cash | -145.23M |
| Net Cash Per Share | -$16.84 |
| Equity (Book Value) | -386.11M |
| Book Value Per Share | -163.47 |
| Working Capital | -275.58M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$123.22 million and capital expenditures -$2.33 million, giving a free cash flow of -$125.55 million.
| Operating Cash Flow | -123.22M |
| Capital Expenditures | -2.33M |
| Free Cash Flow | -125.55M |
| FCF Per Share | -$14.56 |
Full Cash Flow StatementMargins
Gross margin is 20.77%, with operating and profit margins of -9.81% and -14.38%.
| Gross Margin | 20.77% |
| Operating Margin | -9.81% |
| Pretax Margin | -10.62% |
| Profit Margin | -14.38% |
| EBITDA Margin | -8.13% |
| EBIT Margin | -9.81% |
| FCF Margin | n/a |
Dividends & Yields
NeueHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.42% |
| Shareholder Yield | n/a |
| Earnings Yield | -317.76% |
| FCF Yield | -214.11% |
Analyst Forecast
The average price target for NeueHealth is $7.00, which is 2.94% higher than the current price. The consensus rating is "Hold".
| Price Target | $7.00 |
| Price Target Difference | 2.94% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on May 22, 2023. It was a reverse split with a ratio of 0.0125:1.
| Last Split Date | May 22, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.0125:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |